Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Merck (MRK) PT Raised to $68 at Credit Suisse; Sees Multiple Catalysts Ahead
February 5, 2018 7:11 AM ESTCredit Suisse raised its price target on Merck (NYSE: MRK) to $68.00 (from $67.00) while maintaining an Outperform rating.
Analyst Vamil Divan said they continue to see MRK and expect to see further upside as we see the full data for KEYNOTE-189, as well... More
Merck (MRK) Tops Q4 EPS by 4c, Offers FY Guidance
February 2, 2018 6:47 AM ESTMerck (NYSE: MRK) reported Q4 EPS of $0.98, $0.04 better than the analyst estimate of $0.94. Revenue for the quarter came in at $10.4 billion versus the consensus estimate of $10.49 billion.
GUIDANCE:
Merck sees FY2018 EPS of $4.08-$4.23, versus the consensus of $4.11 on revenue of $41.2 to... More
